The role of striatal NMDA receptors in drug addiction.
The past decade has witnessed an impressive accumulation of evidence indicating that the excitatory amino acid glutamate and its receptors, in particular the N-methyl-D-aspartate (NMDA) receptor subtype, play an important role in drug addiction. Various lines of research using animal models of drug addiction have demonstrated that drug-induced craving is accompanied by significant upregulation of NR2B subunit expression. Furthermore, selective blockade of NR2B-containing NMDA receptors in the striatum, especially in the nucleus accumbens (NAc) can inhibit drug craving and reinstatement. The purpose of this review is to examine the role of striatal NMDA receptors in drug addiction. After a brief description of glutamatergic innervation and NMDA receptor subunit distribution in the striatum, we discuss potential mechanisms to explain the role of striatal NMDA receptors in drug addiction by elucidating signaling cascades involved in the regulation of subunit expression and redistribution, phosphorylation of receptor subunits, as well as activation of intracellular signals triggered by drug experience. Understanding the mechanisms regulating striatal NMDA receptor changes in drug addiction will provide more specific and rational targets to counteract the deleterious effects of drug addiction.
Ma
Yao-Ying
YY
Stefan & Shirley Hatos Center for Neuropharmacology, University of California Los Angeles, Los Angeles, California, USA.
Cepeda
Carlos
C
Cui
Cai-Lian
CL
D000818:Animals; D018698:Glutamic Acid / Q000502:physiology; D006801:Humans; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D013569:Synapses / Q000187:drug effects / Q000473:pathology
D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid